Skip to main content

COVID-19 Topic Center

Parkinson Disease Expert Insights

Annals of Long-Term Care
Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for off episodes for this patient population.   
Annals of Long-Term Care
Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate device-aided therapies are lacking.   Reference…
Annals of Long-Term Care
Parkinson disease (PD) is a neurodegenerative disease estimated to afflict approximately 1 million Americans and 10 million people worldwide, with about 60,000 new cases diagnosed every year in the United States.1,2 There are an estimated 5.2% to 6.8% of long-term care (LTC) residents with PD.3-5…
Annals of Long-Term Care
Approximately 60,000 Americans are diagnosed with Parkinson disease (PD) each year, according to the Parkinson Foundation. Diagnosing PD can be challenging, as there are no objective tests to make a definitive diagnosis. However, new research presented at the American Neurological Association’s…
Annals of Long-Term Care
According to the results of a new study, early treatment with levodopa for the treatment of Parkinson disease (PD) had no disease-modifying effect and it is not detrimental to disease course.   Currently, levodopa is the main treatment used for the symptoms of PD. Researchers sought to determine…
Back to Top